Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone densitometry: patients receiving prolonged steroid therapy

M Erlichman1, T V Holohan

  • 1U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Rockville, MD, USA.

Health Technology Assessment
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Cryosurgery for recurrent prostate cancer following radiation therapy.

Health technology assessment·2002
Same author

Evaluation of the approach of primary care physicians to the management of streptococcal pharyngotonsillitis. IPROS Network.

The Israel Medical Association journal : IMAJ·2000
Same author

Therapeutic controversy: Pancreas transplantation for type I diabetes.

The Journal of clinical endocrinology and metabolism·1998
Same author

The federal role in health technology assessment.

Lancet (London, England)·1996
Same authorSame journal

Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease.

Health technology assessment·1996
Same authorSame journal

Bone densitometry: patients with end-stage renal disease.

Health technology assessment·1996
Same journal

18F-labeled 2-deoxy-2-fluoro-D-glucose positron-emission tomography scans for the localization of the epileptogenic foci.

Health technology assessment·1998
Same journal

Signal-averaged electrocardiography.

Health technology assessment·1998
Same journal

Plethysmography: safety, effectiveness, and clinical utility in diagnosing vascular disease.

Health technology assessment·1996
See all related articles

Bone densitometry measures bone density to assess osteoporosis and fracture risk. This report details technical aspects and clinical use, especially for patients on prolonged steroid therapy, evaluating bone loss and prevention strategies.

Area of Science:

  • Medical Imaging
  • Endocrinology
  • Bone Metabolism

Background:

  • Osteoporosis and bone mass loss are linked to conditions like hyperparathyroidism and treatments such as prolonged steroid therapy.
  • Bone densitometry is crucial for assessing osteoporosis severity and fracture risk.

Purpose of the Study:

  • To review technical considerations of bone densitometers, including radiation dose, site selection, accuracy, precision, cost, and charges.
  • To evaluate the clinical utility of bone densitometry in managing patients on prolonged steroid therapy, focusing on bone loss and fracture risk.

Main Methods:

  • Discusses various bone densitometry techniques: SPA, DPA, DXA, QCT, and RA.
  • Analyzes bone loss patterns, fracture risks, and management options for steroid-induced osteoporosis.

Related Experiment Videos

Main Results:

  • Part I covers technical aspects of bone densitometry devices.
  • Part II examines the clinical utility of bone densitometry in steroid-treated patients, addressing bone loss and fracture prevention.

Conclusions:

  • Bone densitometry is essential for diagnosing and monitoring osteoporosis, particularly in patients undergoing prolonged steroid therapy.
  • Understanding technical parameters and clinical applications aids in managing bone health and preventing fractures in at-risk populations.